ES2095331T3 - Tecnica de ensayo. - Google Patents

Tecnica de ensayo.

Info

Publication number
ES2095331T3
ES2095331T3 ES91919411T ES91919411T ES2095331T3 ES 2095331 T3 ES2095331 T3 ES 2095331T3 ES 91919411 T ES91919411 T ES 91919411T ES 91919411 T ES91919411 T ES 91919411T ES 2095331 T3 ES2095331 T3 ES 2095331T3
Authority
ES
Spain
Prior art keywords
substrate
pct
moiety
analogue
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91919411T
Other languages
English (en)
Inventor
Grenville Arthur Robinson
John Gordon Rowan Hurrell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Research Systems ARS Holding NV
Original Assignee
Applied Research Systems ARS Holding NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems ARS Holding NV filed Critical Applied Research Systems ARS Holding NV
Application granted granted Critical
Publication of ES2095331T3 publication Critical patent/ES2095331T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Electroluminescent Light Sources (AREA)
  • Catalysts (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A UNA TECNICA DE VERIFICACION DE LIGADURA COMPETITIVA PARA SUSTANCIAS (P.EJ. MOLECULAS PEQUEÑAS QUE NO DISPONEN DE DETERMINANTES ANTIGENOS) QUE PUEDEN SERVIR COMO SUBSTRATOS PARA ENZIMAS QUE REQUIEREN COENZIMAS. LA TECNICA INCLUYE TAMBIEN EL CONTACTO DE UNA MUESTRA LIQUIDA EN UN SISTEMA DE VERIFICACION INCLUYENDO (I) UNA ESTRUCTURA ANALOGA DE SUBSTRATO Y (II) UNA MITAD CON CAPACIDAD DE LIGADURA ESPECIFICA AL SUBSTRATO. EL SUBSTRATO DE ESTRUCTURA ANALOGA ES UNA SUSTANCIA CON CAPACIDAD DE LIGADURA A LA MITAD MENCIONADA DE FORMA COMPETITIVA CON CUALQUIER OTRA SUSTANCIA PRESENTE EN LA MUESTRA. LA PRESENCIA O CANTIDAD DEL SUBSTRATO SE DETERMINA MEDIANTE MONITORIZACION DE EXTENSION A LA QUE SE HAN FORMADO O PERMANECEN COMPUESTOS COMPLEJOS ENTRE LA MITAD MENCIONADA Y LA ESTRUCTURA ANALOGA DE SUBSTRATO Y/O SUBSTRATO DE FORMA RESPECTIVA.
ES91919411T 1990-10-15 1991-10-14 Tecnica de ensayo. Expired - Lifetime ES2095331T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909022304A GB9022304D0 (en) 1990-10-15 1990-10-15 Assay technique

Publications (1)

Publication Number Publication Date
ES2095331T3 true ES2095331T3 (es) 1997-02-16

Family

ID=10683700

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91919411T Expired - Lifetime ES2095331T3 (es) 1990-10-15 1991-10-14 Tecnica de ensayo.

Country Status (12)

Country Link
US (1) US5356780A (es)
EP (1) EP0553233B1 (es)
JP (1) JP3127301B2 (es)
AT (1) ATE146883T1 (es)
AU (1) AU653176B2 (es)
CA (1) CA2088368C (es)
DE (1) DE69123852T2 (es)
DK (1) DK0553233T3 (es)
ES (1) ES2095331T3 (es)
GB (1) GB9022304D0 (es)
GR (1) GR3022832T3 (es)
WO (1) WO1992007266A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544193B2 (en) * 1996-09-04 2003-04-08 Marcio Marc Abreu Noninvasive measurement of chemical substances
US6120460A (en) * 1996-09-04 2000-09-19 Abreu; Marcio Marc Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions
US5859937A (en) * 1997-04-04 1999-01-12 Neomecs Incorporated Minimally invasive sensor
WO2001002600A2 (en) * 1999-07-06 2001-01-11 General Atomics Detection of analytes using attenuated enzymes
US7192729B2 (en) * 1999-07-06 2007-03-20 General Atomics Methods for assaying homocysteine
EP1206213B1 (en) 1999-08-26 2005-01-26 Novartis AG Ocular analyte sensor
WO2001018237A1 (en) * 1999-09-10 2001-03-15 University Of Maryland, Baltimore Inactive enzymes as non-consuming sensors
EP1424549A1 (en) * 2001-08-07 2004-06-02 Mitsubishi Chemical Corporation SURFACE PLASMON RESONANCE SENSOR CHIP, AND SAMPLE ANALYSIS METHOD AND ANALYSIS APPARATUS USING THE SAME
DE10163775A1 (de) 2001-12-22 2003-07-03 Roche Diagnostics Gmbh Analysensystem zur Bestimmung einer Analytkonzentration unter Berücksichtigung von proben- und analytunabhängigen Lichtintensitätsänderungen
EP1565100A4 (en) 2002-04-22 2008-11-19 Marcio Marc Abreu APPARATUS AND METHOD FOR MEASURING BIOLOGICAL PARAMETERS
US8849379B2 (en) * 2002-04-22 2014-09-30 Geelux Holdings, Ltd. Apparatus and method for measuring biologic parameters
US9848815B2 (en) 2002-04-22 2017-12-26 Geelux Holdings, Ltd. Apparatus and method for measuring biologic parameters
US8328420B2 (en) 2003-04-22 2012-12-11 Marcio Marc Abreu Apparatus and method for measuring biologic parameters
KR101002194B1 (ko) * 2002-05-16 2011-01-13 에프. 호프만-라 로슈 아게 중합체 층의 제조 방법
US10227063B2 (en) 2004-02-26 2019-03-12 Geelux Holdings, Ltd. Method and apparatus for biological evaluation
DK1951110T3 (da) 2005-10-24 2013-01-21 Marcio Marc Aurelio Martins Abreu Apparatur til måling af biologiske parametre
CA2980062A1 (en) 2013-10-11 2015-04-16 Marcio Marc Abreu Method and apparatus for biological evaluation
JP2017505657A (ja) 2014-01-10 2017-02-23 マーシオ マーク アブリュー Ａｂｒｅｕ脳トンネルでモニタして治療を提供するデバイス
CN106102566A (zh) 2014-01-10 2016-11-09 马尔西奥·马克·阿布雷乌 用于测量abreu脑热通道的红外输出的装置
AU2015209304A1 (en) 2014-01-22 2016-07-21 Marcio Marc Abreu Devices configured to provide treatment at an Abreu brain thermal tunnel
EP3267877A1 (en) 2015-03-10 2018-01-17 Marcio Marc Abreu Devices, apparatuses, systems, and methods for measuring temperature of an abtt terminus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU588245B2 (en) * 1984-06-13 1989-09-14 Inverness Medical Switzerland Gmbh Devices for use in chemical test procedures
US4810635A (en) * 1986-04-16 1989-03-07 Miles Inc. Specific binding assays employing label analog to reduce sample interferences
IL85137A (en) * 1987-01-21 1992-02-16 Ares Serono Res & Dev Ltd Method of assaying for a ligand using surface plasmon resonance effect

Also Published As

Publication number Publication date
GB9022304D0 (en) 1990-11-28
EP0553233A1 (en) 1993-08-04
EP0553233B1 (en) 1996-12-27
AU653176B2 (en) 1994-09-22
JPH06504425A (ja) 1994-05-26
AU8668391A (en) 1992-05-20
JP3127301B2 (ja) 2001-01-22
WO1992007266A1 (en) 1992-04-30
CA2088368A1 (en) 1992-04-16
ATE146883T1 (de) 1997-01-15
DE69123852T2 (de) 1997-07-17
DE69123852D1 (de) 1997-02-06
CA2088368C (en) 2003-04-22
GR3022832T3 (en) 1997-06-30
US5356780A (en) 1994-10-18
DK0553233T3 (da) 1997-04-21

Similar Documents

Publication Publication Date Title
ES2095331T3 (es) Tecnica de ensayo.
ATE316147T1 (de) Enzymsensor
DE69412137D1 (de) Sensoreinrichtung zum sandwichtest
SE9504046D0 (sv) Method of determining affinity and kinetic properties
SE7705303L (sv) Forfarande for bestemning av substrat eller enzymaktiviteter medelst en redox-reaktion
DE68917438D1 (de) Durch die Verwendung von Substraten, deren Fluoreszenzeigenschaften sich von denen der umgewandelten Produkte unterscheiden, gekennzeichnete Methode zur Bestimmung der Enzymaktivität.
ATE89566T1 (de) Molekuele mit mindestens einer peptidsequenz einer oder mehrerer epitopen eines p.falciparum- produzierten proteins in hepatozyten und zusammensetzungen davon.
FR2602592B1 (fr) Utilisation du systeme enzymatique xanthine-oxydase en immuno-analyse, procedes de dosage correspondants et coffrets de reactifs necessaires pour la mise en oeuvre de ces procedes.
DE69106002D1 (de) Testverfahren und reagenziensatz dafür.
DE69322959D1 (de) Sensor für optische prüfung
DE60037864D1 (de) Enzymhemmungsimmunverfahren
ATE85363T1 (de) Verfahren und reagenz zur bestimmung von alphaamylase.
Zherdev et al. Homogeneous enzyme immunoassay for pyrethroid pesticides and their derivatives using bacillary alpha-amylase as label
ATE44621T1 (de) Proteinkonjugate von penicillosaeure, ihre herstellung und verwendung.
DE69027988D1 (de) Autoantikörper zur steigerung der chemischen reaktionsgeschwindigkeit
DE59010919D1 (de) N- und O-substituierte Aminophenolderivate, Zwischenprodukte zu deren Herstellung, deren Verwendung als Hydrolasesubstrate, ein entsprechendes Bestimmungsverfahren und hierfür geeignetes diagnostisches Mittel
EP0121254A3 (en) Process for determining substrate or enzymatic activity
FR2435526B1 (fr) Procede et appareil pour l'hydrolyse de sucre, proteines ou substances analogues
DE69010545D1 (de) Extraktionsverfahren.
DK0571485T3 (da) 3-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmåde til fremstilling deraf samt farmaceutisk præparat indeholdende disse forbindelser
ATE209357T1 (de) Biosensor mit auf einer signalaktiven oberfläche kovalent fixiertem biomaterial
DE3484912D1 (de) Peptidderivate und deren verwendung als substrate zur quantitativen bestimmung von enzymen.
FR2660197B1 (fr) Anticorps purifies specifiquement diriges contre les lipopolysaccharides (lps) des bacteries gram negatif.
KR940004326A (ko) 티록신 또는 트리요오도티로닌의 측정을 위한 방법 및 표준용액
DE69516162D1 (de) Mikrobiologisches Verfahren zur Herstellung von 1-ungesättigten, 17-beta-carboxysubstituierten 3-Oxo-4-Azaandrostan-3-onen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 553233

Country of ref document: ES